Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldman, H. I.
Right arrow Articles by Wright, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, H. I.
Right arrow Articles by Wright, J. T.
J Am Soc Nephrol 14:S148-S153, 2003
© 2003 American Society of Nephrology


Supplement Article

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods

Harold I. Feldman, Lawrence J. Appel, Glenn M. Chertow, Denise Cifelli, Borut Cizman, John Daugirdas, Jeffrey C. Fink, Eunice D. Franklin-Becker, Alan S. Go, L. Lee Hamm, Jiang He, Tom Hostetter, Chi-yuan Hsu, Kenneth Jamerson, Marshall Joffe, John W. Kusek, J. Richard Landis, James P. Lash, Edgar R. Miller, Emile R. Mohler, III, Paul Muntner, Akinlolu O. Ojo, Mahboob Rahman, Raymond R. Townsend and Jackson T. Wright and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators

Correspondence to Dr. Harold I. Feldman, Associate Professor of Medicine and Epidemiology, Center for Clinical Epidemiology and Biostatistics, 923 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104. Phone: 215-898-0901; Fax: 215-898-0643

ABSTRACT. Insights into end-stage renal disease have emerged from many investigations but less is known about the epidemiology of chronic renal insufficiency (CRI) and its relationship to cardiovascular disease (CVD). The Chronic Renal Insufficiency Cohort (CRIC) Study was established to examine risk factors for progression of CRI and CVD among CRI patients and develop models to identify high-risk subgroups, informing future treatment trials, and increasing application of preventive therapies. CRIC will enroll approximately 3000 individuals at seven sites and follow participants for up to 5 yr. CRIC will include a racially and ethnically diverse group of adults aged 21 to 74 yr with a broad spectrum of renal disease severity, half of whom have diagnosed diabetes mellitus. CRIC will exclude subjects with polycystic kidney disease and those on active immunosuppression for glomerulonephritis. Subjects will undergo extensive clinical evaluation at baseline and at annual clinic visits and via telephone at 6 mo intervals. Data on quality of life, dietary assessment, physical activity, health behaviors, depression, cognitive function, health care resource utilization, as well as blood and urine specimens will be collected annually. 125I-iothalamate clearances and CVD evaluations including a 12-lead surface electrocardiogram, an echocardiogram, and coronary electron beam or spiral CT will be performed serially. Analyses planned in CRIC will provide important information on potential risk factors for progressive CRI and CVD. Insights from CRIC should lead to the formulation of hypotheses regarding therapy that will serve as the basis for targeted interventional trials focused on reducing the burden of CRI and CVD. E-mail: hfeldman@cceb.med.upenn.edu




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. H. Ix, R. Katz, B. Kestenbaum, L. F. Fried, H. Kramer, C. Stehman-Breen, and M. G. Shlipak
Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. S. DeLoach and R. R. Townsend
Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 184 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. A. Stevens, J. Coresh, H. I. Feldman, T. Greene, J. P. Lash, R. G. Nelson, M. Rahman, A. E. Deysher, Y. Zhang, C. H. Schmid, et al.
Evaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2749 - 2757.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. A. Desai, A. M. Garber, and G. M. Chertow
Rise of Pay for Performance: Implications for Care of People with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend
The treatment of coronary artery disease in patients with chronic kidney disease
QJM, November 1, 2006; 99(11): 723 - 736.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. L. Furth, S. R. Cole, M. Moxey-Mims, F. Kaskel, R. Mak, G. Schwartz, C. Wong, A. Munoz, and B. A. Warady
Design and Methods of the Chronic Kidney Disease in Children (CKiD) Prospective Cohort Study
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1006 - 1015.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. Thadhani and M. Tonelli
Cohort Studies: Marching Forward
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1117 - 1123.
[Full Text] [PDF]


Home page
QJMHome page
A. Ahmad, P. Roderick, M. Ward, R. Steenkamp, R. Burden, D. O'Donoghue, D. Ansell, and T. Feest
Current chronic kidney disease practice patterns in the UK: a national survey
QJM, April 1, 2006; 99(4): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Rahman, S. Pressel, B. R. Davis, C. Nwachuku, J. T. Wright Jr., P. K. Whelton, J. Barzilay, V. Batuman, J. H. Eckfeldt, M. A. Farber, et al.
Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate
Ann Intern Med, February 7, 2006; 144(3): 172 - 180.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. W. Schrier
Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor?
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 1 - 8.
[Abstract] [Full Text]


Home page
CJASNHome page
J. P. Briggs and T. H. Hostetter
Opening Words for CJASN
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 3 - 5.
[Full Text] [PDF]


Home page
NEJMHome page
A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-y. Hsu
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
N. Engl. J. Med., September 23, 2004; 351(13): 1296 - 1305.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Appel
Beyond (or Back to) Traditional Risk Factors: Preventing Cardiovascular Disease in Patients with Chronic Kidney Disease
Ann Intern Med, January 6, 2004; 140(1): 60 - 61.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP